Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Guidance For Economic Evaluation and Budget Impact Analysis For Pharmaceuticals in Catalonia (Spain)Mora-Ripoll, R ; Gilabert-Perramon, A ; Oliva-Moreno, J ; Puig-Junoy, JValue in health, 2014-11, Vol.17 (7), p.A447-A447 [Periódico revisado por pares]United StatesTexto completo disponível |
|
2 |
Material Type: Artigo
|
National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal NeovascularisationBalañá, M ; Ruiz-Moreno, JM ; Roura, MValue in health, 2015-11, Vol.18 (7), p.A419-A419 [Periódico revisado por pares]United StatesTexto completo disponível |
|
3 |
Material Type: Artigo
|
Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain: A Delphi StudyPaz, S ; Torrent, J ; Poveda, JL ; Perez, J ; Moreno, JL ; Martin, A ; Gonzalez, L ; Cruz, J ; Comellas, M ; Abaitua, I ; Urcelay, JValue in health, 2015-11, Vol.18 (7), p.A679-A679 [Periódico revisado por pares]United StatesTexto completo disponível |
|
4 |
Material Type: Artigo
|
Análisis de Costo-Efectividad de Anidulafungina en el Tratamiento de la Candidiasis Invasiva en ColombiaDiaz, J A ; Urrego-Novoa, J R ; Moreno, J A ; Huerfano, C ; Prieto, V AValue in health, 2015-11, Vol.18 (7), p.A870 [Periódico revisado por pares]United StatesTexto completo disponível |
|
5 |
Material Type: Artigo
|
Costo-Efectividad De Un Programa De Nefroproteccion En Una Cohorte De 17.000 Pacientes Con Enfermedad Renal Cronica Afiliados A Una Aseguradora En Salud En ColombiaGuarin, N E ; Arevalo, H O ; Moreno, J A ; Diaz, J A ; Muñoz-Galindo, I MValue in health, 2015-11, Vol.18 (7), p.A827 [Periódico revisado por pares]United StatesTexto completo disponível |
|
6 |
Material Type: Artigo
|
PIN27 COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF ACELLULAR PERTUSSIS IN COLOMBIAN ADOLESCENTSDe la Hoz, F ; Alvis, N ; Moreno, J ; Alvis, L ; Paternina, AValue in health, 2011, Vol.14 (3), p.A118-A118 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
7 |
Material Type: Artigo
|
PDB35 Assessing the Effect of Including Social Costs in Economic Evaluations: A Systematic Review of Diabetes-Related InterventionsLopez-Bastida, J. ; Rodríguez-Sánchez, B. ; Aranda-Reneo, I. ; Oliva-Moreno, J.Value in health, 2020-12, Vol.23, p.S511-S512 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
PRO19 THE ROLE PLAYED BY SOCIAL COSTS IN ECONOMIC EVALUATIONS OF RARE DISEASE INTERVENTIONSLopez Bastida, J. ; Aranda-Reneo, I. ; Peña-Longobardo, L.M. ; Rodríguez-Sánchez, B. ; Oliva-Moreno, J.Value in health, 2019-11, Vol.22, p.S844-S844 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
9 |
Material Type: Artigo
|
PDG86 ECONOMIC EVALUATION FOR PRICING AND REIMBURSEMENT OF NEW DRUGS IN SPAIN: FABLE OR DESIDERATUM?Epstein, D. ; Oliva-Moreno, J. ; Puig-Junoy, J. ; Trapero-Bertran, M. ; Pinyol, C. ; Sacristan, J.A.Value in health, 2019-11, Vol.22, p.S611-S611 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
10 |
Material Type: Artigo
|
PND35 Social Costs in Multiple Sclerosis Economic Evaluations: Do Their Inclusion Change the Results and Conclusions? a Systematic ReviewLopez-Bastida, J. ; Cicchetti, A. ; Rodríguez-Sánchez, B. ; Daugbjerg, S. ; Peña-Longobardo, L.M. ; Aranda-Reneo, I. ; Oliva-Moreno, J.Value in health, 2020-12, Vol.23, p.S628-S629 [Periódico revisado por pares]Elsevier IncTexto completo disponível |